Caldwell Christopher A 4
4 · Concentrix Corp · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Concentrix CEO Christopher Caldwell Receives Award, Sells Shares for Taxes
What Happened
Christopher A. Caldwell, President, CEO and Director of Concentrix Corporation (CNXC), had 2,855 restricted stock units (RSUs) vest on January 28, 2026 (award/acquisition). To satisfy tax withholding, 1,210 shares were disposed at $36.32 per share, generating $43,947. The award shares are reported as acquired at $0.00 because they were issued upon vesting.
Key Details
- Transaction dates: January 28, 2026 (vesting and tax-withholding disposition); Form 4 filed January 30, 2026 (appears timely).
- Award: 2,855 shares issued upon RSU vesting (code A) — acquired at $0.00 on the vesting date.
- Tax withholding/disposition: 1,210 shares withheld/disposed (code F) at $36.32 per share for a total of $43,947.
- Shares owned after transaction: Not reported on this Form 4.
- Footnote: The RSUs were originally awarded under the 2020 Stock Incentive Plan on January 27, 2023 and vested after performance metrics measured over the three-year period ending November 30, 2025 (per footnote F1).
- Filing timeliness: No late filing flag; Form 4 was filed within the typical 2-business-day window.
Context
- This was an award vesting with shares issued and a routine tax-withholding disposition — common practice when executives receive RSUs.
- The disposition to cover taxes does not necessarily indicate a market sell decision beyond meeting withholding obligations.
Insider Transaction Report
Form 4
Concentrix CorpCNXC
Caldwell Christopher A
DirectorPresident and CEO
Transactions
- Award
Common Stock
[F1]2026-01-28+2,855→ 362,285 total - Tax Payment
Common Stock
2026-01-28$36.32/sh−1,210$43,947→ 361,075 total
Footnotes (1)
- [F1]Represents shares issued upon the vesting of restricted stock units awarded under the 2020 Stock Incentive Plan on January 27, 2023, subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2025.
Signature
/s/ Andrew A. Farwig, Attorney-in-Fact|2026-01-30